The European Commission approved a fifth biosimilar that will compete with AbbVie's mega-blockbuster biologic Humira, generic drugmaker Mylan said Wednesday. Mylan's Hulio snagged an OK for all of Humira's indications.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,